Each guide identifies five key priorities for the area of risk, and gives a heads-up on why each is a priority area. The priority is explained in further detail, with a series of mini-checklists and action points.
Having a clear understanding of the nature of competition law compliance and the associated risks/challenges for businesses is the first step to setting effective compliance arrangements. We help organisations with this.
Practical guidance tools, registers, training aids and other templates to help you comply with data protection law and manage privacy risks
Helping in-house counsel, privacy and compliance professionals manage the regulatory burden. GDPR, BA, MLR and plenty more, we've got it covered.
This week's edition of Risk & Compliance weekly highlights includes updates to the ICO's guidance on transfer risk assessments and international data...
Law360, Expert analysis: 2025 brought the financially regulated community many gifts in the form of promised reforms. Michael Lewis, partner and head...
The European Commission has proposed a new cybersecurity package aimed at addressing increasingly sophisticated cyber and hybrid threats facing the...
Corporate Crime analysis: Rahman Ravelli’s legal director, Dr. Angelika Hellweger and associate, Tatiana Novikova outline the UK’s approach to...
EU Law analysis: Regulation (EU) 2025/2518 (the Procedural Regulation) lays down EU-wide procedural rules for the enforcement of the EU General Data...
Enhancing watch list screeningScreening is a crucial element in sanctions due diligence. However, the complex nature of watch list screening creates...
New and updated content 2026—Risk & ComplianceThis Practice Note tells you, on a month-by-month basis, whether we have made substantive amendments to...
How to complete a transfer risk assessment—international data transfer—ICO methodologySTOP PRESS: This Practice Note is being updated to reflect...
How to complete a transfer impact assessment—international data transfer—EU methodologySTOP PRESS: This Practice Note is being updated to reflect...
Appointing a European representative—data protectionSTOP PRESS: This Practice Note is being updated to reflect revised ICO guidance on international...
Message from CEO/Senior Member/Senior Partner on the introduction of a financial sanctions policyFrom [insert name and job title]1Policy statementWe...
Message from CEO reinforcing the financial sanctions policyFrom [Insert name and job title]1Policy statementWe run our business[es] with integrity....
International data transfer—data recipient questionnaireSTOP PRESS: This Precedent is being updated to reflect revised ICO guidance on international...
Transfer impact assessment—personal data—EU methodologySTOP PRESS: This Precedent is being updated to reflect revised ICO guidance on international...
Fraud risk management policy1Introduction1.1Fraud is a major issue affecting individuals and businesses in every country and in every sector.1.2Fraud...
How to plan and conduct an internal investigationAn internal investigation is a legal process undertaken by an organisation (with or without outside...
Anti-bribery and corruption—post-training assessment answersQuestionCorrect answer1. How many new offences does the Bribery Act 2010 create? (b)...
Money Laundering Regulations 2017—scope and applicationThis Practice Note sets out the scope and application of the Money Laundering, Terrorist...
Money Laundering Regulations 2017—nominated officerThis Practice Note sets out when organisations must appoint a nominated officer (sometimes referred...
Sanctions regime—RussiaThe Russia (Sanctions) (EU Exit) Regulations 2019, SI 2019/855, made under the Sanctions and Anti-Money Laundering Act 2018...
How to manage legal riskIt is often said that running a business means taking risks and that the biggest risk an entrepreneur can take is not to think...
Contract management risk management guideWhy you need to manage this riskContract management is often seen by the business as an activity which is...
Competition law compliance—post-training assessment answersQuestionCorrect answer1. Competition law protects business and consumers from...
SRA Code of Conduct for Solicitors, RELs and RFLs—for in-house lawyersThis Practice Note provides guidance for in-house solicitors on the SRA Code of...
Anti-bribery and corruption—post-training assessment questionsHow to use this testThese questions are designed to test your understanding after your...
How to create a legal risk registerThis Practice Note is intended for in-house lawyers. It explains how to create a legal risk register, a tool that...
Tipping-off and prejudicing an investigationThere are several offences of tipping-off and prejudicing an investigation that apply to the regulated...
Confidentiality risk management guideWhy you need to manage this riskConfidential information is one of the most valuable assets of any business....
Records retention schedule1Introduction1.1This Record retention schedule accompanies and is incorporated into [insert organisation’s name]’s Records...
Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017—key information for businessesThe Money...
The merger control rules of the UK are contained in the Enterprise Act 2002, as amended. Under the UK merger control rules, the Competition and Markets Authority has jurisdiction to review both completed and anticipated merger transactions provided there is a ‘relevant merger situation’. The UK rules do not generally apply to mergers in relation to which the European Commission has exclusive jurisdiction under the EU Merger Regulation. Where the transaction falls within the scope of any national or supranational (eg the EU or COMESA) merger control rules, it is common for the parties to the agreement to agree that the transaction shall be conditional upon merger control approvals having been received and no relevant competition authority having raised objections to the transaction (Enterprise Act 2002).
Another term for reference medicinal product, which has been granted a authorisation'>marketing authorisation (MA) on the basis of a complete dossier in accordance with Articles 8(3), 10a, 10b or 10c of Directive 2001/83/EC, and to which the application for MA for a generic medicinal product refers, by demonstration of bioequivalence.
A ‘prohibited list’ is a list: • which contains details of persons who: ? are or have been members of trade unions, or ? are taking part or have taken part in trade union activities, and • is compiled with a view to being used by employers or employment agencies for the purpose of discrimination in relation to recruitment or the treatment of workers